Trump’s Lunch Biggest Memecoin Event Draws Investors Again
A private luncheon for the largest holders of a Trump-themed memecoin is back at Mar-a-Lago, renewing headlines about...
When To Choose Or Avoid Target Date Funds In Retirement
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articles
Authorities Arrest Missing Suspect in Ledger Co-Founder Kidnapping
Authorities arrest missing suspect in the Ledger co-founder kidnapping, marking a major breakthrough after weeks of p...
Tether Wins Big Four Audit After Years of Harsh Treatment
Tether has hired its first full independent audit from a Big Four firm, marking a major step toward transparency afte...
1.5m+ People Spend Their Week in Headsets, Pre-IPO Round Nears Close
A tiny pre-IPO tech winner is closing its round for retail investors as millions log hours in VR workspaces. Here’s w...
Takes Meta Almost Minutes to Profit, Google Sprints Ahead
Alphabet’s Q1 2026 results show a rapid profit pace that dwarfs Meta’s earnings, underscoring a widening gap in AI-dr...
Trump Heads China: Goldman Sachs Says Dollar Is Overvalued
With Trump heading to China for high-stakes talks, Goldman Sachs flags a dollar overvaluation of roughly 12-15% versu...
Dram Drops Memory Trade After Parabolic Rally, ETF Falls
The Roundhill Memory ETF fell roughly 5% in early trading after a dramatic six-week breakout. Analysts say profit-tak...
NVIDIA Month Rally Could Earnings Change the Course
NVIDIA’s stock has surged roughly 20% over the past month as markets brace for the May earnings release. Analysts and...
Strategy Uses Bitcoin Sales Table for Debt Buybacks
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
College Students Booing Commencement Spotlight AI Debate
Graduates at several universities faced boos as speakers praised AI, even as the same cohort leans on AI tools for st...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Startup $200 Million ARR: When Fame Was Lost, Then Found
A bold creator-turned-CEO describes walk-away decisions, cash crunch, and a hard pivot that ended in a $200 million A...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status